Gerresheimer, DE000A0LD6E6

Gerresheimer focuses on pharma packaging operations, shares anchored in MDAX context

Published on 06/24/2026 at 07:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer starts midweek without a fresh corporate announcement but with its established role in drug and cosmetics packaging and a steady MDAX presence setting the frame for investors.

Gerresheimer, DE000A0LD6E6, Illustration mit AI erstellt.
Gerresheimer, DE000A0LD6E6, Illustration mit AI erstellt.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-24, 07:02.

Gerresheimer (DE000A0LD6E6) remains a core packaging supplier to the global pharmaceuticals and cosmetics industry. The stock is listed in the MDAX on Xetra, giving the group a visible role in Germany's mid-cap index universe.

Industrial packaging role today

Gerresheimer supplies vials, syringes, ampoules and other primary packaging components to drug makers, backed by long-term contracts and regulatory approvals. The company also serves cosmetics brands with glass and plastic containers, a combination that diversifies its revenue base.

The group positions itself as a systems partner rather than a pure container producer, offering design support and quality assurance processes for regulated markets. This operational approach aims to secure recurring orders and stable utilization of its production sites.

Wednesday operations focus

On a Wednesday, investors often look past short-term price moves to the underlying operations. Gerresheimer's production network extends across Europe, North America and emerging markets, which helps the company supply multinational clients with standardized packaging formats.

Regulatory compliance is central to its business model, as pharmaceutical packaging must meet strict safety standards. Gerresheimer invests in certification and traceability, which can strengthen its competitive position and support contract renewals with large drug manufacturers.

Go deeper

Background and price data on Gerresheimer

For more figures, historical performance and additional news on the Gerresheimer shares, the following links provide structured information.

The product behind the stock

One representative product line is Gerresheimer's glass vials and syringes used for injectable medicines, including vaccines and biologics. These containers are designed to meet pharmaceutical quality standards and support safe drug administration in hospital and outpatient settings.

Where the stock trades today

The Gerresheimer shares (DE000A0LD6E6) trade on Xetra, the main electronic market of Deutsche Börse in Frankfurt. A precise live-verified price for 2026-06-24, 07:02 in euros is not available here, but the listing provides continuous trading in the German mid-cap segment.

Key data on the Gerresheimer shares

  • Company: Gerresheimer AG
  • ISIN: DE000A0LD6E6
  • WKN: A0LD6E
  • Ticker: GXI
  • Trading venue: Xetra
  • Price (as of 2026-06-24, 07:02): not live-verified in this text
  • Market cap: latest verified figure not stated here
  • Sector / industry: Health Care equipment and supplies, packaging
  • Index membership: MDAX
  • Next earnings date: not officially scheduled

More on the Gerresheimer shares in social media

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Figures and facts are based on publicly available information believed to be reliable at the time of review.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000A0LD6E6 | GERRESHEIMER | boerse | 69615635 | bgmi